Standard Biotools (LAB) Change in Receivables (2010 - 2026)

Standard Biotools (LAB) has 17 years of Change in Receivables data on file, last reported at $1.9 million in Q1 2026.

• Change in Receivables for Q1 2026 came in at $1.9 million, down 8.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 119.14% YoY), and the FY2025 annual result was $1.4 million, up 115.18% from the prior year.
• Change in Receivables grew to $1.9 million in Q1 2026 per LAB's latest filing, from -$6.7 million in the prior quarter.
• Over five years, Change in Receivables peaked at $6.2 million in Q3 2022 and troughed at -$6.7 million in Q4 2025.
• A 5-year average of -$224705.9 and a median of $276000.0 in 2025 frame the typical range for Change in Receivables.
• The sharpest annual moves came in 2023 and 2024: Change in Receivables surged 6013.33% in 2023, then plunged 648.29% in 2024.
• A 5-year view of Change in Receivables shows it stood at $60000.0 in 2022, then surged by 6013.33% to $3.7 million in 2023, then slumped by 282.52% to -$6.7 million in 2024, then fell by 0.52% to -$6.7 million in 2025, then jumped by 127.61% to $1.9 million in 2026.
• Business Quant data shows LAB's Change in Receivables at $1.9 million in Q1 2026, -$6.7 million in Q4 2025, and $5.8 million in Q3 2025.